KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Amortization - Intangibles (2017 - 2025)

Historic Amortization - Intangibles for TherapeuticsMD (TXMD) over the last 5 years, with Q3 2025 value amounting to $32000.0.

  • TherapeuticsMD's Amortization - Intangibles fell 6666.67% to $32000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $216000.0, marking a year-over-year decrease of 4844.87%. This contributed to the annual value of $7699.0 for FY2017, which is 2887.1% down from last year.
  • Latest data reveals that TherapeuticsMD reported Amortization - Intangibles of $32000.0 as of Q3 2025, which was down 6666.67% from $88000.0 recorded in Q1 2025.
  • TherapeuticsMD's Amortization - Intangibles' 5-year high stood at $190000.0 during Q2 2024, with a 5-year trough of $32000.0 in Q3 2025.